US22663K1079
US22663K1079
Crinetics Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 7.696.000 | 1.039.000 | 640.7% |
| Cost of Revenue | 1.076.000 | -- | -- |
| Gross Profit | 6.620.000 | 1.039.000 | 537.2% |
| 523.389.000 | 339.893.000 | 54.0% | |
| Operating Income | -516.769.000 | -338.854.000 | 52.5% |
| Pretax Income | -465.137.000 | -298.408.000 | 55.9% |
| Net Income Common Stockholders | -465.317.000 | -298.408.000 | 55.9% |
| -- | -- | -- | |
| -- | -- | -- |